Recombinant HHV8 抗体
Quick Overview for Recombinant HHV8 抗体 (ABIN6937459)
抗原
抗体类型
适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
纯化方法
- Purified by Protein A/G
-
免疫原
- Recombinant protein corresponding to the latent nuclear antigen 1 molecule of HHV8
-
亚型
- IgG1 kappa
-
-
anti-Herpes Virus Type 8 (HHV8) antibody
HHV8 适用: 人 IHC (p) 宿主: 大鼠 Monoclonal LN53 unconjugated
anti-Herpes Virus Type 8 (HHV8) (C-Term) antibodyHHV8 适用: 人 WB, EIA 宿主: 兔 Polyclonal unconjugated
-
-
应用备注
-
Positive Control: Herpes simplex type 1 (HSV-1) extract or infected cells. Tissue.
Known Application: ELISA (For coating use Ab at 1-5 μg/mL, order Ab without BSA), Optimal dilution for a specific application should be determined.
-
限制
- 仅限研究用
-
-
-
缓冲液
- 10 mM PBS without BSA and without Azide.
-
储存液
- Azide free
-
储存条件
- 4 °C,-80 °C
-
储存方法
- Antibody with azide - store at 2 to 8°C. Antibody without azide - store at -20 to -80°C. Antibody is stable for 24 months.
-
有效期
- 24 months
-
-
- HHV8 (Herpes Virus Type 8 (HHV8))
-
别名
- Human Herpes Virus 8 (HHV8)
-
物质类
- Virus
-
背景
- HHV 8 encodes a latent nuclear antigen (LNA), which is the product of the viral gene orf 73. LNA is capable of forming a complex with retinoblastoma susceptibility gene product, which may be related to its oncogenic activity. HHV8 is associated with three different diseases observed in AIDS patients, kaposi's sarcoma, primary effusion lymphoma (which is a rare type of non-Hodgkin lymphoma affecting the body cavities) and multicentric Castleman's disease. HHV 8 is the likely etiological agent of Kaposis sarcoma.
抗原
-
